Jazz Pharmaceuticals (JAZZ) FCF Margin Growth (3y) (2013 - 2026)
Jazz Pharmaceuticals (JAZZ) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | -453.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -453.00 |
| Dec 31, 2025 | 6,226.00 |
| Sep 30, 2025 | -7,636.00 |
| Jun 30, 2025 | -2,392.00 |
| Mar 31, 2025 | 2,207.00 |
| Dec 31, 2024 | 1,352.00 |
| Sep 30, 2024 | 616.00 |
| Jun 30, 2024 | 2,589.00 |
| Mar 31, 2024 | -1,776.00 |
| Dec 31, 2023 | -573.00 |
| Sep 30, 2023 | -1,499.00 |
| Jun 30, 2023 | -97.00 |
| Mar 31, 2023 | -1,565.00 |
| Dec 31, 2022 | 1,722.00 |
| Sep 30, 2022 | -1,833.00 |
| Jun 30, 2022 | 866.00 |
| Mar 31, 2022 | -1,408.00 |
| Dec 31, 2021 | -2,656.00 |
| Sep 30, 2021 | -1,295.00 |
| Jun 30, 2021 | -3,464.00 |